Table: begin end state 1 29 non-cytoplasmic 30 47 transmembrane 48 54 cytoplasmic 55 75 transmembrane 76 86 non-cytoplasmic 87 104 transmembrane 105 124 cytoplasmic 125 147 transmembrane 148 164 non-cytoplasmic 165 186 transmembrane 187 192 cytoplasmic 193 211 transmembrane 212 222 non-cytoplasmic 223 252 transmembrane 253 272 cytoplasmic 273 293 transmembrane 294 313 non-cytoplasmic 314 344 transmembrane 345 356 cytoplasmic 357 382 transmembrane 383 387 non-cytoplasmic 388 411 transmembrane 412 429 cytoplasmic 430 448 transmembrane 449 457 non-cytoplasmic 458 475 transmembrane 476 482 cytoplasmic 483 516 transmembrane 517 525 non-cytoplasmic 526 550 transmembrane 551 553 cytoplasmic 554 572 transmembrane 573 578 non-cytoplasmic 579 604 transmembrane 605 618 cytoplasmic 619 640 transmembrane 641 647 non-cytoplasmic
Input: >H281DRAFT_05541 MNDLFSNIATQDLHIAEAPAKVGGRVITSSAWGFGTLSTGGHLLATLCTFIERLCAVVLG MDVLVVFVSVILRYFVHQPVDWAEEVARGLMIMMVFLGGATVLARRQHVNIDFFRALLPL AWRAVALQIGYWVIAGTAGGLAYSAWLLLQDSANVTTPMGLPQWLNVLPVLLGALLMTVV AVASAIAGAPRTIWLTLLACCIAAAALWGWNTEFEQYAVAPCAMLLAGFVGGLMVGVPIA FVLALSALLYFISDPSLPMIVYSQQVMAGMDHFVLLAIPFFVLAGLVMEVNGMSSRLIEL LVRIFGRVRGSMNLIAILATAFFSGVSGSKLADIAAVGGIVVPAVRRTKQDPNETAAVLA ASGVMAETIPPCINMIIIGFVANISIGGLFLAGIVPAVVMAIALATLVVIFGKKIEPKTA FESRRPICRLLGGALVALVMVIMIGKGVTSGVATSTEVSSFAVVYALVIGGFTFRELTPG AIAALFVRAAAMAAGILFIIAAASSVAFALTILQIPAMLSAGMLALAHNYGSVAFLAVSV LIMIVFGAILEGAPALIIFGPLLVPIAVHVGVNPLHFGTIAVTAMGLGLFSPPFGLGLCA TCAMTGTRIEDVSRRMFKYLALLVVMLVLLVLVPSISLWLPRHFNMV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server